Nervio

About Nervio

Nervio has created AIM™, an AI-powered intraoperative neuromonitoring platform that transforms raw surgical data into real-time alerts and recommendations, effectively augmenting the capabilities of neurophysiologists. This technology addresses the shortage of qualified neuromonitoring experts, enhancing surgical safety and operational efficiency in healthcare settings.

```xml <problem> Intraoperative neuromonitoring (IONM) is a complex process prone to human error, and a shortage of qualified neurophysiologists limits its use, with only a fraction of neurosurgeries currently monitored. This can lead to increased risk during surgery and erode profit margins for healthcare providers. </problem> <solution> Nervio's AIM™ is an AI-powered intraoperative neuromonitoring platform designed to augment the capabilities of neurophysiologists and improve surgical safety. AIM™ converts raw surgical data into real-time alerts and recommendations, effectively adding an expert neurophysiologist to the team. The system is built on machine learning algorithms and has been tested on over 1,000 surgeries. It serves as a vigilant adjunct to existing IONM systems, rapidly identifying critical changes in IONM data and presenting them in a simple visual display. </solution> <features> - AI-powered analysis of raw surgical data for real-time alerts and recommendations - Machine learning algorithms trained on data from over 1,000 surgeries - Visual display of critical changes in IONM data - Adjunct to standard IONM platforms - Streamlines operations and reduces workload for neurophysiologists - Improves data mining quality - Allows expansion into untapped markets </features> <target_audience> The primary users are hospitals, neurophysiologists, and surgeons seeking to improve surgical safety, reduce the risk of human error, and address the shortage of qualified neuromonitoring experts. </target_audience> ```

What does Nervio do?

Nervio has created AIM™, an AI-powered intraoperative neuromonitoring platform that transforms raw surgical data into real-time alerts and recommendations, effectively augmenting the capabilities of neurophysiologists. This technology addresses the shortage of qualified neuromonitoring experts, enhancing surgical safety and operational efficiency in healthcare settings.

Employees
48 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Nervio

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Nervio has created AIM™, an AI-powered intraoperative neuromonitoring platform that transforms raw surgical data into real-time alerts and recommendations, effectively augmenting the capabilities of neurophysiologists. This technology addresses the shortage of qualified neuromonitoring experts, enhancing surgical safety and operational efficiency in healthcare settings.

Funding

No funding information available.

Team (40+)

No team information available.

Company Description

Problem

Intraoperative neuromonitoring (IONM) is a complex process prone to human error, and a shortage of qualified neurophysiologists limits its use, with only a fraction of neurosurgeries currently monitored. This can lead to increased risk during surgery and erode profit margins for healthcare providers.

Solution

Nervio's AIM™ is an AI-powered intraoperative neuromonitoring platform designed to augment the capabilities of neurophysiologists and improve surgical safety. AIM™ converts raw surgical data into real-time alerts and recommendations, effectively adding an expert neurophysiologist to the team. The system is built on machine learning algorithms and has been tested on over 1,000 surgeries. It serves as a vigilant adjunct to existing IONM systems, rapidly identifying critical changes in IONM data and presenting them in a simple visual display.

Features

AI-powered analysis of raw surgical data for real-time alerts and recommendations

Machine learning algorithms trained on data from over 1,000 surgeries

Visual display of critical changes in IONM data

Adjunct to standard IONM platforms

Streamlines operations and reduces workload for neurophysiologists

Improves data mining quality

Allows expansion into untapped markets

Target Audience

The primary users are hospitals, neurophysiologists, and surgeons seeking to improve surgical safety, reduce the risk of human error, and address the shortage of qualified neuromonitoring experts.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.